Analysts forecast that Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) will announce earnings per share (EPS) of ($0.28) for the current quarter, according to Zacks. Three analysts have issued estimates for Inovio Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.34) and the highest estimate coming in at ($0.25). Inovio Pharmaceuticals reported earnings […]
Zacks Investment Research downgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a buy rating to a sell rating in a report released on Friday, Zacks.com reports. According to Zacks, “Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) issued its earnings results on Tuesday. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.18), MarketWatch Earnings reports. The business had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.55 million. Inovio Pharmaceuticals […]